Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy
Files
Self archived version
published versionDate
2015Author(s)
Unique identifier
10.1186/s13014-015-0392-xMetadata
Show full item recordMore information
Self-archived item
Citation
Virén, Tuomas. Heikkilä, Janne. Myllyoja, Kimmo. Koskela, Kristiina. Lahtinen, Tapani. Seppälä, Jan. (2015). Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy. Radiation Oncology, 10 (1) , 79. 10.1186/s13014-015-0392-x.Rights
Abstract
Background
The aim of the present study was to introduce a new restricted tangential volumetric modulated arc therapy (tVMAT) technique for whole breast irradiation and compare its dosimetric properties to other currently used breast cancer radiotherapy techniques.
Method
Ten consecutive women with left-sided breast cancer were enrolled in this retrospective study. Four treatment plans were generated for each patient: 1) standard tangential field-in-field (FinF), 2) tangential intensity modulated radiotherapy (tIMRT), 3) tangential VMAT (tVMAT) with two dual arcs of 50-60° and 4) continuous VMAT (cVMAT) with a dual arc of 240°. The plans were created with Monaco® (tIMRT, tVMAT and cVMAT) and Oncentra® (FinF) treatment planning systems.
Results
With both VMAT techniques significantly higher cardiac avoidance, dose coverage and dose homogenity were achieved when compared with FinF or tIMRT techniques (p < 0.01). VMAT techniques also decreased the high dose areas (above 20 Gy) of ipsilateral lung. There were no significant differences in the mean dose of contralateral breast between the tVMAT, tIMRT and FinF techniques. The dose coverage (V47.5 Gy) was greatest with cVMAT. However, with cVMAT the increase of contralateral breast dose was significant.
Conclusions
The present results support the hypothesis that the introduced tVMAT technique is feasible for treatment of left-sided breast cancer. With tVMAT dose to heart and ipsilateral lung can be reduced and the dose homogeneity can be improved without increasing the dose to contralateral breast or lung.